Sunday, January 25, 2009 8:45:26 AM
"Next week, the market will have to digest more than 1,100 earnings reports and a number of important economic reports, including existing- and new-home sales on Monday and Thursday and the first report on gross domestic product on Friday.
Reports are due from 11 Dow companies, including Caterpillar (CAT, news, msgs), DuPont (DD, news, msgs), AT&T (T, news, msgs), Chevron (CVX, news, msgs) and Exxon Mobil (XOM, news, msgs)."
Recent BOLT News
- Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/21/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 06:29:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 06:27:52 PM
- Bolt Biotherapeutics to Present at the TD Cowen 44th Annual Healthcare Conference • GlobeNewswire Inc. • 02/27/2024 12:00:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/13/2024 02:41:27 AM
- Form 5 - Annual statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 06:09:39 PM
- Pacira Appoints Frank D. Lee as Chief Executive Officer • GlobeNewswire Inc. • 12/21/2023 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/13/2023 06:40:19 PM
- Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu® • GlobeNewswire Inc. • 12/05/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:10:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:08:11 PM
- Bolt Biotherapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/09/2023 09:05:00 PM
- Bolt Biotherapeutics to Present at Stifel 2023 Healthcare Conference • GlobeNewswire Inc. • 11/07/2023 12:00:00 PM
- Bolt Biotherapeutics Presents Updated Clinical Data from Phase 1 Dose-Escalation Trial of BDC-1001 as Monotherapy and in Combination with Nivolumab in HER2-Expressing Tumors at ESMO 2023 Congress • GlobeNewswire Inc. • 10/23/2023 02:30:00 PM
- Bolt Biotherapeutics to Present Data at the Society for Immunotherapy of Cancer’s 2023 Annual Meeting • GlobeNewswire Inc. • 10/18/2023 11:00:00 AM
- Bolt Biotherapeutics Announces First Patient Dosed in Phase 1/2 Study of BDC-3042 in Patients with Advanced Cancers • GlobeNewswire Inc. • 10/17/2023 11:00:00 AM
- Bolt Biotherapeutics to Present New Clinical Data from Completed Phase 1/2 Dose-Escalation Trial of BDC-1001 in HER2-Expressing Solid Tumors at the ESMO Congress 2023 • GlobeNewswire Inc. • 10/16/2023 11:00:00 AM
- Bolt Biotherapeutics Receives Orphan Drug Designation for BDC-1001 for Treatment of Gastric Cancers • GlobeNewswire Inc. • 09/28/2023 11:00:00 AM
- Bolt Biotherapeutics Announces Issuance of U.S. Patent Covering Dectin-2-Targeting Agonist Antibodies, Including BDC-3042 • GlobeNewswire Inc. • 09/12/2023 12:05:25 PM
- Bolt Biotherapeutics to Participate in September Investor Conferences • GlobeNewswire Inc. • 09/05/2023 08:15:00 PM
- Bolt Biotherapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/07/2023 08:10:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2023 08:08:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2023 08:06:09 PM
- Bolt Biotherapeutics Initiates Phase 2 Clinical Studies of BDC-1001 in Patients With HER2-Positive Cancer • GlobeNewswire Inc. • 08/03/2023 11:30:00 AM
- Bolt Biotherapeutics to Present at BTIG Virtual Biotechnology Conference 2023 • GlobeNewswire Inc. • 07/31/2023 09:27:56 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM